Researchers from Boston University School of Medicine (BUSM) have found that patients with node-negative T3 and T4 lung non-small suffered chemotherapy before surgery had more than three times of the survival of patients who underwent the surgery only. These results are currently on-line in the journal of thoracic and cardiovascular surgery.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment